Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: A study in 22 patients; is it a fortuitous finding?

Hematological Oncology

Volumn 17, Issue 3, 1999, Pages 107-116

  Jelic, Svetislav ^a   Filipović Lješković, Ivana ^a  

^a Inst onkologiju radiologiju Srbije   (Serbia)

Author keywords

Borrelia burgdorferi; ELISA; Immunoblot; Primary cutaneous B cell lymphoma; Serology

Indexed keywords

ARTICLE; B CELL LYMPHOMA; BORRELIA; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SEROLOGY;

EID: 0342979779     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199909)17:3<107::AID-HON644>3.0.CO;2-R     Document Type: Article

References (35)

1. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphoma; Part 1: Gastrointestinal, cutaneous and genitourinary lymphoma. Ann Oncol 1997; 8: 727-737.
2. Vorobeva NN, Volegova GM. Burylov AI, Tkachenko GA, Kozminykh EV, Alypova II. The clinical picture and course of the nonerythematous form of ixodid tick-borne borreliosis. Med Parazito 1995; 3: 12-15.
3. Anthonissen FM, De Kessel M, Hoet RR, Bigaignon GM. Evidence for the involvement of different genospecies of Borrelia in the clinical outcome of Lyme disease in Belgium. Res Microbiol 1994; 145: 327-339.
4. Wang G, van Dam AP, Le Fleche A, et at. Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacterial 1997; 47(4): 926-932.
5. Nakao M, Miyamoto K. Mixed infection of different Borrelia species among Apodemus speciosus mice in Hokkaido, Japan. J Clin Microbiol 1995; 33: 490-492.
6. Kirstein F, Rijpkema S, Molkenboer M, Gray JS. The distribution and prevalence of B. burgdorferi genomospecies in ixodes ricinus in Ireland. Eur J Epidemiol 1997; 13: 67-72.
7. Demaerschalck I, Ben Messaoud A, De Kessel M, et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol 1995; 33: 602-608.
8. Garbe C, Stein M, Dienmaun D, Orfanos CE. Borrelia burgdorferi associated cutaneous B-cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991; 14: 584-590.
9. Garbe C, Stein M, Gallnick H, Tand W, Orfanos CF. Kutanes B-zell Lymphom bei chronicher Borrelia burgdorferi Infection: Bericht uber zwei Galle und Literaturbersicht. Hantarzt 1988; 39: 717-726.
10. LeBoih RE, McNutt NS, Reed JA, Jacob M, Weiss LM. Primary cutaneous immunocytoma, a B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol 1994; 18: 969-978.
11. Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Palhol 1997; 24(8): 457-461.
12. Jelić S. A recently recognized association: Lyme disease Borrelia infection and primary cutaneous B-cell lymphomas. J BUON 1998; 3: 199-206.
13. Kerl H, Cerroni L. Primary B-cell lymphomas of the skin. Ann Oncol 1997; 8(suppl. 2): S29-S32.
14. Hilton E, Devoti J, Sood S. Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease. J Clin Microbiol 1996; 34(6): 1353-1354.
15. Wilske B, Hauser U, Lehnert G, Jauris-Heipke S. Genospecies and their influence on immunoblot results. Wien Klin Wochenschr 1998; 110(24): 882-885.
16. Hulinska D. Diagnosis of Lyme borreliosis with western blotting. Epidemiol Mikrobiol Immunol 1997; 46(1): 3-8.
17. Honegr K, Hulinska D, Havlasova J, Dostal V. Importance of the immunoblot test in the diagnosis of Lyme borreliosis. Epidemiol Mikrobiol Immunol 1997; 46(4): 149-154.
18. Bunikis J, Olsen B, Westman G, Bergstroom S. Variable serum immunoglobulin responses against different Borrelia burgdorferi sensu lato species in a population at risk and patients with Lyme disease. J Clin Microbiol 1995; 33(6): 1473-1478.
19. Rijpkema S, Golubić D, Molkenboer M, Verbeek-De Kruif N, Schellekens J. Identification of four genomic groups of Borrelia burgdorferi sensu lato in ixodes ricinus ticks collected in a Lyme borreliosis endemic region of northern Croatia. Exr Appl Acarol 1996; 20: 23-30.
20. Picken RN, Cheng Y, Strle F, et al. Molecular characterization of Borrelia burgdorferi sensu lato from Slovenia revealing significant differences between tick and human isolates. Eur J Clin Microbiol Infect Dis 1996; 15: 313-323.
21. Busch U, Hizo-Teufel C, Bohmer R, et al. Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borrelia biopsies differentiated by pulsed-field gel electrophoesis. Scand J Infect Dis 1996; 28: 583-589.
22. Peter O, Bretz AG, Bee D. Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland. Eur J Epidemiol 1995; 11: 463-467.
23. Kirstein F, Rijpkema S, Molkenboer M, Gray JS. Local variations in the distribution and prevalence of Borrelia burgdorferi sensu lato genomospecies in ixodes ricinus ticks. Appl Environ Microbiol 1997; 63: 1102-1106.
24. Ohlenbusch A, Matuschka FR, Richter D, et al. Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 1996; 174(2): 421-423.
25. Picken RN, Strle F, Picken MM, et al. Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrohicans lesions. J Invest Dermatol 1998; 110(3): 211-214.
26. Nilsson I, von Rosen IA. Serum antibodies against Borrelia afzelii, Borrelia burgdorferi sensu stricto and 41-kiloDalton flagellin in patients from a Lyme borreliosis endemic area: analysis by EIA and immunoblot. APMIS 1996; 104(12): 907-914.
27. Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999; 130(1): 32-36.
28. Brehmer-Andersson E, Hovmark A, Asbrink E. Acrodermatitis chronica atrophicans: histopathologic findings and clinical correlations in 111 cases. Acta Derm Venereol 1998; 78(3): 207-213.
29. Aberer E. The dermatologic spectrum of Lyme borreliosis. Wien Med Wochenschr 1995; 145(7-8): 165-170.
30. Sonck CE, Viljanen M, Hirsimaki P, Soderstrom KO, Ekfors TO. Borrelial lymphocytoma - a historical case. APMIS 1998; 106(10): 947-952.
31. Isaacson PG, Norton AJ (eds). Extranodal Lymphomas. Edinburgh: Churchill Livingstone, 1994.
32. Ma Y, Stwoorock A, Wess JJ. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun 1991; 59: 671-678.
33. Shoenfeld R, Araneo B, Ma Y, Yang LM, Weis JJ. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen Borrelia burgdorferi. Infect Immun 1992; 6: 455-464.
34. Fahrer H, Sauvain MJ, Zhioua E, Van Hoecke C, Gern LE. Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals? Eur J Epidemiol 1998; 14(2): 117-123.
35. Kutting B, Bonsmann G, Metze D, Luger TA, Cerroni L. Borrelia burgdorferi-associated primary cutaneous B-cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 1997; 36(2): 311-314.